BR0014438A - Formulação para mulheres na menopausa - Google Patents

Formulação para mulheres na menopausa

Info

Publication number
BR0014438A
BR0014438A BR0014438-0A BR0014438A BR0014438A BR 0014438 A BR0014438 A BR 0014438A BR 0014438 A BR0014438 A BR 0014438A BR 0014438 A BR0014438 A BR 0014438A
Authority
BR
Brazil
Prior art keywords
formulation
menopausal women
menopause
women
premenopausal
Prior art date
Application number
BR0014438-0A
Other languages
English (en)
Inventor
Saul R Levinson
Marc S Hermelin
Mitchell I Kirschner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR0014438A publication Critical patent/BR0014438A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Otolaryngology (AREA)

Abstract

"FORMULAçãO PARA MULHERES NA MENOPAUSA". A presente descoberta refere-se a novas composições as quais fornecem suporte nutricional aumentado para mulheres na pré- menopausa e menopausa e/ou alívio de sintomas associados com menopausa, bem como efeitos profiláticos, e métodos para usar o mesmo.
BR0014438-0A 1999-09-30 2000-08-28 Formulação para mulheres na menopausa BR0014438A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/409,059 US6479545B1 (en) 1999-09-30 1999-09-30 Formulation for menopausal women
PCT/US2000/023527 WO2001024772A1 (en) 1999-09-30 2000-08-28 Formulation for menopausal women

Publications (1)

Publication Number Publication Date
BR0014438A true BR0014438A (pt) 2002-08-20

Family

ID=23618887

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014438-0A BR0014438A (pt) 1999-09-30 2000-08-28 Formulação para mulheres na menopausa

Country Status (14)

Country Link
US (5) US6479545B1 (pt)
EP (1) EP1216024B1 (pt)
JP (1) JP2003510344A (pt)
KR (1) KR100831511B1 (pt)
CN (1) CN1391464A (pt)
AT (1) ATE357213T1 (pt)
AU (1) AU778507B2 (pt)
BR (1) BR0014438A (pt)
CA (2) CA2385854C (pt)
DE (2) DE60034046T2 (pt)
ES (1) ES2195798T3 (pt)
MX (1) MXPA02003101A (pt)
WO (1) WO2001024772A1 (pt)
ZA (1) ZA200202633B (pt)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0862445B2 (en) * 1995-10-06 2017-03-22 Arch Development Corporation Combination of herpes simplex virus and chemotherapy for treating cancer
AU4988000A (en) * 1999-05-07 2000-11-21 Trustees Of Tufts College Immune stimulating dietary supplement and methods of use thereof
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
MXPA03004817A (es) * 2000-11-29 2003-09-10 Smithkline Beecham Corp Composicion dietetica conteniendo acido linoleico conjugado y calcio para salud mejorada.
AR033042A1 (es) * 2001-03-16 2003-12-03 Wyeth Corp Terapia de reemplazo hormonal
AT411327B (de) * 2001-08-23 2003-12-29 Heil Bettina Hormonpräparat mit ungesättigten fettsäuren
US7704542B2 (en) * 2001-09-12 2010-04-27 Xanodyne Pharmaceuticals, Inc. Vitamin/mineral compositions with DHA
US6911438B2 (en) * 2001-09-12 2005-06-28 Jonathan V. Wright Hormone replacement formulation
NL1019368C2 (nl) * 2001-11-14 2003-05-20 Nutricia Nv Preparaat voor het verbeteren van receptorwerking.
US6821532B2 (en) * 2001-11-16 2004-11-23 Unitel Technologies, Inc. Methods and compositions for the treatment of benign prostatic hypertrophy
MXPA04008185A (es) * 2002-02-21 2004-11-26 Schering Ag Composiciones farmaceuticas que comprenden uno o mas esteroides, uno o mas componentes de tetrahidrofolato y vitamina b12.
AU2003218319A1 (en) * 2002-03-22 2003-10-13 Doc's Guide, Inc. Multivitamin and mineral nutritional supplement
US6610331B1 (en) * 2002-05-30 2003-08-26 Scott M. Sweazy Fertility kit
EP1517667A2 (en) * 2002-07-02 2005-03-30 Galileo Pharmaceuticals, Inc. Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
CA2490308A1 (en) * 2002-07-12 2004-01-22 University Of Rochester Use of amino acids for treatment of various conditions
NZ569868A (en) 2002-09-27 2010-01-29 Martek Biosciences Corp Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation
US20050064013A1 (en) * 2002-10-11 2005-03-24 Jeffrey Liebrech Ready to drink beverage composition having liquid form HGH pre-cursor and method of making same
GB0228571D0 (en) * 2002-12-06 2003-01-15 Novartis Ag Organic compounds
TWI322691B (en) * 2003-04-11 2010-04-01 Follicle-stimulating hormone reducing agent
US20040253319A1 (en) * 2003-06-11 2004-12-16 Shrirang Netke Pharmaceutical compositions and method for alleviating side-effects of estrogen replacement therapy
IL156670A0 (en) * 2003-06-26 2004-01-04 Zvi Zolotariov Aloe suppositories
US7857913B2 (en) * 2003-06-26 2010-12-28 Spindler William E Cleaning compound for cleaning surfaces in a food processing environment
US20050032741A1 (en) * 2003-08-06 2005-02-10 Balaji Venkataraman Vitamin Compositions
US20050032740A1 (en) * 2003-08-06 2005-02-10 Balaji Venkataraman Vitamin compositions for the treatment and prevention of vascular disease and dementia
JP2005075804A (ja) * 2003-09-03 2005-03-24 Toyo Capsule Kk メナテトレノン含有医薬組成物
US7875291B1 (en) 2003-09-05 2011-01-25 Glu-Pro, Inc. Composition for managing diabetes, obesity, and hyperlipidemia and associated methods
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
EP1667619A4 (en) * 2003-09-19 2007-10-10 Drugtech Corp PHARMACEUTICAL FEEDING SYSTEM
US20050112215A1 (en) * 2003-10-09 2005-05-26 Valerie Otto Cramp bark extract and method of extraction
US20050158404A1 (en) * 2003-11-18 2005-07-21 Goodless Dean R. Composition and method for treatment of acne
US20050202038A1 (en) * 2004-03-10 2005-09-15 Green Roger E. Composition and method for minimizing residual fecal matter in the perianal area
CA2563237C (en) * 2004-04-07 2012-10-09 Rutgers, The State University Of New Jersey Appetite-suppressing compositions and methods
GB2414181A (en) * 2004-05-19 2005-11-23 Merck & Co Inc compositions containing a bisphosphonate and a Vitamin D derivative
US20050266130A1 (en) * 2004-05-28 2005-12-01 Henry Aoki Method for solidification and storing of components extracted from plant, animal, or mineral matter and extract components extracted from held plant, animal, or mineral matter
US20060039971A1 (en) * 2004-08-19 2006-02-23 Lee Robert E Effervescent composition including alternative hormone replacement therapy agent
US20060135610A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Cardiovascular compositions
AU2006244260A1 (en) * 2005-05-09 2006-11-16 Drugtech Corporation Modified-release pharmaceutical compositions
UY29527A1 (es) 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
JP2007023010A (ja) * 2005-07-19 2007-02-01 Toshiro Azegami 閉経後のホルモンバランス調整及びパーキンソン症の予防改善目的の経口組成物
US8202546B2 (en) 2005-08-04 2012-06-19 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US7998500B2 (en) 2005-08-04 2011-08-16 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US7901710B2 (en) 2005-08-04 2011-03-08 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US8263137B2 (en) 2005-08-04 2012-09-11 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US20070048367A1 (en) * 2005-08-31 2007-03-01 Mom Enterprises, Inc. Herbal composition for treating morning sickness
WO2007073525A2 (en) * 2005-11-28 2007-06-28 Yvonne Daily Hot-flash wipes and clothing
CA2635986A1 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Composition and method of use thereof
KR20080083190A (ko) * 2006-01-05 2008-09-16 드러그테크 코포레이션 외음질 표면에 생체접착을 위한 약물 전달 시스템
CA2637608A1 (en) * 2006-01-20 2007-07-26 Pear Tree Pharmaceuticals, Inc. Method of treating atrophic vaginitis
WO2007143607A2 (en) 2006-06-02 2007-12-13 Pear Tree Women's Health Care Method of treating atrophic vaginitis
US20080057144A1 (en) * 2006-09-01 2008-03-06 Cathy Beggan Wake up on time dietary supplement and method of use
US20080138383A1 (en) * 2006-12-07 2008-06-12 Jonathan David Bortz Compositions and methods for treating seizures
US20130115320A1 (en) 2007-03-30 2013-05-09 Dynova Laboratories, Inc. Therapeutic agent for intranasal administration and method of making and using same
US20080242741A1 (en) * 2007-03-30 2008-10-02 Wayne Jeffrey Perry Intranasal drug delivery system
US20080241290A1 (en) * 2007-03-30 2008-10-02 Wayne Jeffrey Perry Sinus relief composition and method of producing the same
JP5374491B2 (ja) * 2007-04-02 2013-12-25 アビラ，アルフレド 骨折および骨欠損の処置のためのハーブ製剤
US20090053319A1 (en) * 2007-08-21 2009-02-26 Wayne Jeffrey Perry Sore Throat Relief Composition And Method of Producing Same
US20090069446A1 (en) * 2007-09-06 2009-03-12 Wayne Jeffrey Perry Dendritic salt therapeutic agent delivery system
US20090069433A1 (en) * 2007-09-10 2009-03-12 Wayne Jeffrey Perry Nasal rinse additive
US7964189B1 (en) 2007-09-25 2011-06-21 Argent Development Group, Llc Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women
US9125844B1 (en) 2007-09-25 2015-09-08 Argent Development Group, Llc Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women
UY31410A1 (es) * 2007-10-30 2009-05-29 Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado
US7824716B1 (en) * 2008-04-11 2010-11-02 Van De Pol Sylvia Herbal women's health formula
US20090264520A1 (en) * 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
US8535659B1 (en) 2008-05-27 2013-09-17 Argent Development Group, Llc Nutritional supplements for pregnant women
US8535660B1 (en) 2008-05-27 2013-09-17 Argent Development Group, Llc Nutritional supplements for pregnant women
US20100040708A1 (en) * 2008-08-13 2010-02-18 Vicki Boynton Herbal composition
US20100255147A1 (en) * 2009-03-20 2010-10-07 Milk Specialties Company Non-Settling Galacto-Oligosaccharide-Rich Liquid Concentrate and Related Methods and Nutritional Compositions
IT1397405B1 (it) * 2009-06-23 2013-01-10 A M S A S R L Formulazione integrativa finalizzata al controllo delle alterazioni organiche multifattoriali ricorrenti nel periodo della menopausa
LT2782584T (lt) 2011-11-23 2021-09-10 Therapeuticsmd, Inc. Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CN111743999A (zh) * 2013-10-09 2020-10-09 味之素株式会社 抗疲劳组合物
KR101400913B1 (ko) * 2014-03-12 2014-05-28 주식회사 파미니티 여성 호르몬 조절질환의 예방, 치료 또는 개선용 약학 조성물 및 식품용 조성물
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9392814B2 (en) * 2014-06-06 2016-07-19 Nicholas J. Singer Delivery system for drinks
CN104027339B (zh) * 2014-06-12 2017-01-18 王淑芳 一种维生素组合物及其调理卵巢功能应用
AU2015296609A1 (en) 2014-07-29 2016-12-22 Therapeuticsmd, Inc. Transdermal cream
BR112017013886A2 (pt) * 2015-01-14 2018-01-02 Pfizer produto para fornecimento por via oral
USD773313S1 (en) 2015-06-23 2016-12-06 Nicholas J. Singer Package
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
CN105944088A (zh) * 2016-06-29 2016-09-21 中国人民解放军第三军医大学第附属医院 用于调节卵巢功能的组合物及其应用
US10357529B2 (en) * 2016-11-07 2019-07-23 Rvrs, Llc Natural formulation for treating hangover
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US471387A (en) * 1892-03-22 Photographic album
NL8403433A (nl) * 1984-11-09 1986-06-02 Holland Melkunie Voedingssuppletiepreparaat op basis van melkbestanddelen.
GB8524276D0 (en) 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
US4752479A (en) * 1986-05-27 1988-06-21 Ciba-Geigy Corporaton Multi vitamin and mineral dietary supplement with controlled release bioavailable iron
GB8621816D0 (en) * 1986-09-10 1986-10-15 Efamol Ltd Therapeutic composition
US4851431A (en) * 1986-11-26 1989-07-25 Bar Ilan University Physiologically active and nutritional composition
US4900734A (en) 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
DE3854664T2 (de) 1987-10-14 1996-05-02 Kao Corp Verfahren zur Herstellung eines Polyol-Fettsäureesters und dadurch erhaltene Glyceridmischung.
IL91802A (en) * 1988-10-27 1994-05-30 Univ Bar Ilan Preparations containing linoleic acid history for the treatment of Alzheimer's, similar brain diseases, and epilepsy
US5012761A (en) * 1988-11-17 1991-05-07 Oh Suk Y Chicken egg having relatively high percentage of long chain fatty acids and method of reducing heart related disease in humans using such eggs
US4945103A (en) 1989-01-17 1990-07-31 Michael Cohen Method of treating pre-menstrual syndrome
US5514392A (en) * 1989-08-30 1996-05-07 Seawell Corporation N.V. Packaging for perishable goods
GB9112052D0 (en) * 1991-06-05 1991-07-24 Efamol Holdings Fatty acid treatment
US5670201A (en) * 1991-06-21 1997-09-23 Snow Brand Milk Co., Ltd. Low allergenic nutrient composition and method of using same
US5087586A (en) * 1991-07-03 1992-02-11 Micron Technology, Inc. Process for creating fully-recessed field isolation regions by oxidizing a selectively-grown epitaxial silicon layer
US5223285A (en) * 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
GB9211229D0 (en) 1992-05-27 1992-07-08 Efamol Holdings Fatty acid treatment
GB9217780D0 (en) * 1992-08-21 1992-10-07 Efamol Holdings Fatty acid treatment
CA2144751C (en) 1992-09-23 2001-05-01 George Paradissis Multi-vitamin and mineral supplement for pregnant women
CA2143420C (en) * 1992-12-23 1999-01-19 Phyllis J. B. Acosta Medical foods for the nutritional support of infant/toddler metabolic diseases
US5576666A (en) * 1993-11-12 1996-11-19 Nippondenso Technical Center Usa, Inc. Fractional-N frequency synthesizer with temperature compensation
US5855949A (en) * 1994-01-10 1999-01-05 Mclean; Linsey Dietary system high in oil intake
US5484623A (en) * 1994-01-10 1996-01-16 Mclean; Linsey Dietary system high in oil intake for the treatment of obesity and for the lowering of saturated fats
US5869084A (en) * 1994-06-20 1999-02-09 K-V Pharmaceuticals Co. Multi-vitamin and mineral supplements for women
NZ280017A (en) * 1994-09-21 1997-06-24 Scotia Holdings Plc Use of n-6 or n-3 series essential fatty acid (efa), and optionally an oestrogen, to make a medicament to treat or prevent hormone replacement therapy (hrt) associated breast pain in peri- or postmenopausal women; medicaments containing the efa and estrogen.
US5514382A (en) 1994-10-17 1996-05-07 Sultenfuss; Sherry Daily vitamin and mineral supplement for women
US5589468A (en) * 1995-01-13 1996-12-31 Clintec Nutrition Co. Method for providing nutrition to elderly patients
US5569459A (en) 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
US5514328A (en) 1995-05-12 1996-05-07 Stoody Deloro Stellite, Inc. Cavitation erosion resistent steel
GB9510636D0 (en) * 1995-05-25 1995-07-19 Scotia Holdings Plc Fatty acid treatment
US5997915A (en) * 1996-01-31 1999-12-07 South Alabama Medical Science Foundation Compositions for human and animal consumption containing reduced folates and methods for making and using same
CA2261764A1 (en) * 1996-07-30 1998-02-05 Jeffrey B. Blumberg Dietary supplements
US5807586A (en) 1996-07-30 1998-09-15 Energetics, Inc. Method of dietary supplementation
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
US5922704A (en) * 1997-12-24 1999-07-13 Feeling Fine Company Llc Optimal nutritional supplement for men
US6048846A (en) 1998-02-26 2000-04-11 Cochran; Timothy M. Compositions used in human treatment
WO1999065337A1 (en) 1998-06-19 1999-12-23 Beth Israel Deaconess Medical Center Dietary supplement for post-menopausal women
US6569857B1 (en) * 1999-05-03 2003-05-27 Drugtech Corporation Dietary supplement
US6258846B1 (en) * 1999-06-01 2001-07-10 Drugtech Corporation Nutritional supplements
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
JP2008056612A (ja) 2006-08-31 2008-03-13 Koei Chem Co Ltd アミノピリジン類の製造方法

Also Published As

Publication number Publication date
WO2001024772A1 (en) 2001-04-12
CA2385854A1 (en) 2001-04-12
MXPA02003101A (es) 2003-08-20
EP1216024B1 (en) 2007-03-21
US7687485B2 (en) 2010-03-30
US6479545B1 (en) 2002-11-12
EP1216024A1 (en) 2002-06-26
DE00957857T1 (de) 2005-03-31
DE60034046D1 (de) 2007-05-03
CN1391464A (zh) 2003-01-15
AU778507B2 (en) 2004-12-09
CA2385854C (en) 2005-04-12
EP1216024A4 (en) 2005-02-02
DE60034046T2 (de) 2007-12-06
AU6941600A (en) 2001-05-10
ZA200202633B (en) 2003-04-30
KR100831511B1 (ko) 2008-05-22
ES2195798T3 (es) 2007-11-16
US20020173510A1 (en) 2002-11-21
CA2645397A1 (en) 2001-04-12
US20050106266A1 (en) 2005-05-19
ES2195798T1 (es) 2003-12-16
JP2003510344A (ja) 2003-03-18
ATE357213T1 (de) 2007-04-15
US20090068289A1 (en) 2009-03-12
KR20020048424A (ko) 2002-06-22
US20020137749A1 (en) 2002-09-26

Similar Documents

Publication Publication Date Title
BR0014438A (pt) Formulação para mulheres na menopausa
EP1025850A4 (en) COMPOSITIONS CONTAINING ISOFLAVONE
BR0016065A (pt) Composição nutricional
PA8481501A1 (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
MXPA01006917A (es) Composicion topica que comprende n-acetilaldosaminas o acidos n-acetilaminos.
BR0114913A (pt) Inibidores de metaloproteinase de espiro-pirimidina-2,4,6-triona
BR0312232A (pt) Inibidores de caspases e seus usos
ES2187720T3 (es) Procedimiento para la preparacion de composiciones de vitamina b12 de alta concentracion.
MXPA02004933A (es) Composiciones cosmeticas conteniendo extracto de garbanzo y retinoides.
ME00113B (me) Estri l-karnitina ili alkanoil l-karnitina korisni kao katjonski lipidi za unutarćelijsko oslobađanje farmakološki aktivnih jedinjenja
BR0010702A (pt) Novas quinonas como terapias de doenças
BRPI0416686A (pt) composição para obter benefìcios na pele usando intermediários metabólicos celulares chave.
AR021643A1 (es) Combinacion de cerivastatina y fibratos.
ES2170143T3 (es) Composiciones que comprenden halofantrina en una forma especial.
TR200101425T2 (tr) IL-5 inhibe edici 6-azaurasil türevleri
WO2003103625A3 (en) DERMOCOSMETIC TREATMENT WITH METABOLIC PHOSPHOLIPIDS
TH93503S (th) ตู้จ่ายไฟฟ้า
TH12577S1 (th) โต๊ะเครื่องแป้ง
TH47646S (th) โต๊ะเครื่องแป้ง
TH12578S1 (th) โต๊ะเครื่องแป้ง
TH43586S (th) พื้นรองเท้า
TH10956S1 (th) พื้นรองเท้า
TH10957S1 (th) พื้นรองเท้า
TH43591S (th) พื้นรองเท้า
TH13345S1 (th) ชุดอุปกรณ์การทำฟัน

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A, 5A, 6A, E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1929 DE 26/12/2007.